- The company is using its profitable business for dental practices as a cash cow to develop its medical business.
- The medical business is a platform with multiple applications, but efforts are concentrating on Epidural, where its CompuFlo delivers strong benefits.
- It looks like the CompuFlo has a fair shot at catching on and the company has cash for another 18 months to concentrate efforts, but there are no guarantees here.
- So investors need to understand this is a high-risk, high-reward situation.
Milestone Scientific Looks Like Breaking Out
October 3rd, 2019 · No Comments